Galectin Therapeutics Inc. (GALT) at a glance

Galectin Therapeutics Inc. (GALT) is a small-cap Healthcare company. It trades at $3.99, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 57/100 overall. Its strongest dimension is Safety (99/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$3.99

Market cap

$402.4M

P/E ratio

n/a

Dividend yield

None

Beta

0.35

52-week range

$2.03 to $7.13